Previous close | 597.42 |
Open | 601.07 |
Bid | 239.28 x 900 |
Ask | 599.71 x 800 |
Day's range | 597.26 - 601.69 |
52-week range | 492.84 - 654.62 |
Volume | |
Avg. volume | 79,472 |
Market cap | 9.082B |
Beta (5Y monthly) | 0.42 |
PE ratio (TTM) | 33.48 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.60 (0.27%) |
Ex-dividend date | 23 Feb 2024 |
1y target est | N/A |
Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. Global equity markets closed out 2023 with their highest quarterly returns this year, following a period of weakness. In the fourth quarter, the strategy returned 14.87% (gross) and 14.59% (net) […]